Many individuals with schizophrenia experience multiple relapses, which are associated with serious and potentially fatal outcomes. Nonadherence to antipsychotic medications is a major contributor to relapse. By using reliable strategies to measure adherence and identify patients who are not taking their medications as prescribed, clinicians can intervene to possibly prevent relapse or decrease its severity.
From the Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
To cite: Lauriello J. Prevalence and impact of relapse in patients with schizophrenia. J Clin Psychiatry. 2020;81(1):MS19053BR1C. To share:https://doi.org/10.4088/JCP.MS19053BR1C